Mode
Text Size
Log in / Sign up

Non-surgical weight loss reduces AHI by 11.10 in adults with obstructive sleep apnoeaNon-surgical weight loss lowers sleep apnea severity and blood pressure in adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider non-surgical weight loss as a foundational management strategy for obstructive sleep apnoea.

This systematic review and meta-analysis examined the impact of non-surgical weight loss interventions on adults with obstructive sleep apnoea. The analysis included 2242 participants and assessed changes in the Apnea-Hypopnea Index and various cardiometabolic parameters.

The pooled results demonstrated a significant reduction in the Apnea-Hypopnea Index with a mean difference of -11.10 (p < 0.0001). Significant improvements were also observed for body weight (MD = -6.53, p < 0.01), body mass index (MD = -2.40, p < 0.01), waist circumference (MD = -5.13, p < 0.01), neck circumference (MD = -0.97, p < 0.01), systolic blood pressure (MD = -6.51, p < 0.01), and diastolic blood pressure (MD = -3.26, p < 0.01).

The authors note that high heterogeneity (I >90%) existed for most outcomes and that evidence for benefits was most robust in the short to mid-term. The overall certainty of evidence was rated as very low, highlighting the need for high-quality research with extended follow-up to confirm the durability of these benefits.

Sleep apnoea is a serious condition that disrupts sleep and strains the heart. A large analysis of data from 2242 adults found that non-surgical weight loss interventions helped lower the severity of this breathing disorder. The study looked at how much breathing stopped during sleep and measured changes in body weight and blood pressure.

The results showed clear short-term benefits. Breathing interruptions decreased significantly, and participants lost weight. Their waistlines and neck circumferences also shrank, which often helps open airways. Systolic and diastolic blood pressure readings improved as well.

However, the certainty of this evidence was rated as very low. The benefits were most robust in the short to mid-term. High differences between the various studies made it hard to draw firm conclusions. We need high-quality research with extended follow-up to confirm if these improvements last over time.

Non-surgical weight loss constitutes a viable short-to-midterm strategy for improving sleep apnoea severity and cardiometabolic health. It should be integrated as a foundational component of initial management, with emphasis on long-term weight maintenance.

What this means for you:
Non-surgical weight loss improves sleep apnoea and blood pressure in the short to mid-term, but long-term results are uncertain.

Study Details

Study typeMeta analysis
Sample sizen = 2,242
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Obstructive sleep apnoea (OSA) is a prevalent disorder closely linked to obesity. While weight loss is a recommended strategy to target its root cause, evidence on the efficacy and sustainability of non-surgical interventions remains unclear. This meta-analysis aimed to systematically evaluate their effects on OSA severity and cardiometabolic outcomes, and to explore sources of heterogeneity. METHODS: This meta-analysis of randomized controlled trials was conducted PRISMA guidelines (PROSPERO: CRD420250641507). We searched PubMed, EMBASE, Cochrane Library, and Web of Science for trials assessing non-surgical weight loss interventions in adults with OSA. The primary outcome was the Apnea-Hypopnea Index (AHI); secondary outcomes included anthropometric and blood pressure measures. Data were synthesized using random-effects models, with heterogeneity explored via pre-specified subgroup analyses (by follow-up duration and type 2 diabetes status). Risk of bias and evidence certainty (GRADE) were assessed. RESULTS: Eighteen studies involving 2242 participants were included. Non-surgical weight loss interventions significantly reduced AHI (MD = -11.10; p < 0.0001). Significant improvements were observed in all secondary outcomes: body weight (MD = -6.53), body mass index (MD = -2.40), waist circumference (MD = -5.13), neck circumference (MD = -0.97), systolic blood pressure (MD = -6.51), and diastolic blood pressure (MD = -3.26) (all p < 0.01). Evidence for benefits was most robust in the short to mid-term. Heterogeneity was high (I >90%) for most outcomes. The overall certainty of evidence was rated as very low. CONCLUSION: Non-surgical weight loss constitutes a viable short-to-midterm strategy for improving OSA severity and cardiometabolic health. It should be integrated as a foundational component of initial management, with emphasis on long-term weight maintenance. High-quality research with extended follow-up is needed to confirm the durability of benefits.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.